US 2023/0144871 A1Published application

Modulators of the integrated stress pathway

AssigneesCalico Life Sciences LLC, AbbVie Inc.

InventorsKathleen Ann Martin, Carmela Sidrauski, Marina Pliushchev, Yunsong Tong, Xiangdong Xu, Qingwei Zhang, Ramzi Farah Sweis, Michael J. Dart

Life of this patent

Estimating the term…

Abstract

Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.

Claims9

Dependent claims

1-66. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 17/806,905Filed 14 Jun 2022
Priority: 2 Nov 2017
Published: 11 May 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification24 codes

C07D 271/10
Not condensed with other rings: 1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
A61K 31/4245
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: oxadiazoles
A61K 31/4355
Ortho- or peri-condensed with heterocyclic ring systems: the heterocyclic ring system containing a five-membered ring having oxygen as a ring…
A61K 31/4439
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Family

Application62/580,805Us provisional application · filed 2 Nov 2017
Application62/643,067Us provisional application · filed 14 Mar 2018
Application16/761,392Continuation · filed 4 May 2020
Application17/806,905Continuation
US 2020/0361881 A1Published application
US 2023/0144871 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results